Understanding erectile dysfunction medication preference studies

被引：25
|
作者：
Mulhall, JP
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Urol, New York, NY 10021 USA
[3] Presbyterian Hosp, New York, NY USA
来源：
CURRENT OPINION IN UROLOGY | 2004年 / 14卷 / 06期
关键词：
drug trials; erectile dysfunction; pharmacotherapy; preference; sildenafil; tadalafil; vardenafil;
D O I：
10.1097/00042307-200411000-00013
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In the final analysis, it is unclear to this author how preference studies impact upon clinician decision-making when confronted by a patient with erectile dysfunction.
引用
收藏
页码：367 / 373
页数：7
相关论文
共 50 条
  • [41] Erectile Dysfunction Diagnosis and Treatment as a Means to Improve Medication Adherence and Optimize Comorbidity Management
    Scranton, Richard E.
    Goldstein, Irwin
    Stecher, Vera J.
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 (02) : 551 - 561
  • [42] An Overview of the Diagnosis and Treatment of Erectile Dysfunction
    Sivaprakasam Sivalingam
    Hashim Hashim
    Hartwig Schwaibold
    Drugs, 2006, 66 : 2339 - 2355
  • [43] Phosphodiesterase 5 inhibitors for erectile dysfunction
    Setter, SM
    Iltz, JL
    Fincham, JE
    Campbell, RK
    Baker, DE
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1286 - 1295
  • [44] Pharmacotherapy for Erectile Dysfunction in 2021 and Beyond
    Nik-Ahd, Farnoosh
    Shindel, Alan W.
    UROLOGIC CLINICS OF NORTH AMERICA, 2022, 49 (02) : 209 - 217
  • [45] Tadalafil in the treatment of erectile dysfunction.
    Anthony J. Bella
    Gerald B. Brock
    Current Urology Reports, 2003, 4 (6) : 472 - 478
  • [46] Erectile dysfunction in the cardiac patient.
    Robert A. Kloner
    Current Urology Reports, 2003, 4 (6) : 466 - 471
  • [47] Evolution of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction in Taiwan
    Jiann, Bang-Ping
    UROLOGICAL SCIENCE, 2016, 27 (02) : 66 - 70
  • [48] Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction
    Alberto Briganti
    Andrea Salonia
    Federico Deho’
    Giuseppe Zanni
    Luigi Barbieri
    Patrizio Rigatti
    Francesco Montorsi
    World Journal of Urology, 2005, 23 : 374 - 384
  • [49] Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction
    Briganti, A
    Salonia, A
    Deho', F
    Zanni, G
    Barbieri, L
    Rigatti, P
    Montorsi, F
    WORLD JOURNAL OF UROLOGY, 2005, 23 (06) : 374 - 384
  • [50] Effectiveness and treatment satisfaction in patients with erectile dysfunction in Spain: EDOS study
    Martin-Morales, A.
    Gutierrez Hernandez, P. R.
    Meijide Rico, F.
    Arrondo Arrondo, J. L.
    Turbi Disla, C.
    ACTAS UROLOGICAS ESPANOLAS, 2010, 34 (04): : 356 - 364
12345